awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q39411127-1BA40E6B-3041-4D61-B2F6-1BD417A52853
Q39411127-1BA40E6B-3041-4D61-B2F6-1BD417A52853
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39411127-1BA40E6B-3041-4D61-B2F6-1BD417A52853
Potential value of Gleason score in predicting the benefit of cabazitaxel in metastatic castration-resistant prostate cancer.
P2860
Q39411127-1BA40E6B-3041-4D61-B2F6-1BD417A52853
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39411127-1BA40E6B-3041-4D61-B2F6-1BD417A52853
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3b1207b00f4f61fd52255caa68fca41032ca2d31
P2860
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial